The Latest Breaking News from Boston Scientific

Boston Scientific Corp (NYSE:BSX) generated net sales of $3.026 billion in Q1 FY22, beating the Wall Street estimate of $2.95 billion. Sales increased 10% Y/Y on a reported basis, 12.6% on an operational basis, and 9.7% on an organic basis, better than the management estimate of approximately 5% - 8%. The Company achieved…

Boston Scientific eked out a narrow first-quarter beat that also topped industry trends, an analyst said Wednesday as BSX stock popped.

  Boston Scientific (NYSE:BSX) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings Boston Scientific reported in-line EPS of $0.39 versus an estimate of $0.39.

The post-Covid recovery in elective procedures is far from certain. But if it materializes, it could stoke some health care stocks.